“Medical biotechnologies”, “Digital hospital”, and “New Medical Devices” appear among the 34 plans of “industrial recovery” presented by the French president on the 12th of September at Elysée Palace.

McKinsey estimated the potential of these 34 plans to be 480,000 jobs in 10 years and 45.5 billion Euros of generated value – 40% of which for exportation.

The plan “Medical Biotechnologies” will allow the reinforcement of France’s position in terms of synthetic biotechnology and cell therapy by consolidating partnership research and supporting biotechnology companies’ development and offer.

The plan “Digital Hospital” will also allow the government to increase healthcare quality, to control spending and to offer growth opportunities to the French industrial force.

In the medical devices area, the French government’s ambition is to position its industrial offer on high added value segments such as imagery (scanner, ultrasound, endoscopy) or e-health (telecardiology, management and analysis of patient data).